UroToday.com - This a randomized, double-blind, placebo controlled, parallel group, multicenter study involving 200 men with or without erectile dysfunction. Men (25-64 years of age) did not have ejaculatory dysfunction. Subjects were randomized to daily treatment with vardenafil, sildenafil or placebo for Read more…
The U.S. Food and Drug Administration requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person’s blood pressure and can cause other life-threatening side effects. These lots of Xiadafil Read more…
Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that Read more…
Finasteride for prostate cancer
Men’s Health News
Generic lexapro pills no prescription A comprehensive re-evaluation of the largest prostate cancer prevention study ever completed produced new findings suggesting that men and their doctors should consider a more aggressive approach that includes finasteride to prevent the development of prostate Read more…
The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction (ED), provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology.
EHS Read more…
The US Food and Drug Administration (FDA) has received reports of sudden reduction or loss of hearing following the use of PDE5 inhibitors, a class of drugs
that includes the erectile dysfunction (ED) medications Viagra, Levitra, and Cialis and also Revatio, used to treat pulmonary arterial hypertension
(PAH).
The FDA has approved manufacturers’ label changes for the ED drugs that highlight this risk more prominently and advise Read more…
Online Treatment Service For Male Impotence To Be Launched By Chelsea And Westminster And DrThom, UK
Chelsea and Westminster Hospital NHS Foundation Trust becomes the
first NHS body to venture into online treatment by launching a remote
treatment service for erectile dysfunction in partnership with DrThom
(), the UK’s leading online healthcare provider.
Chelsea and Westminster and DrThom will make it easier for the 2.3 million
UK Read more…
Latest News For This Category
Correlation Between Erectile Dysfunction And LUTS The AUA Lecture
19 Apr 2008
A Mixed Set Of Results From 5-Alpha-Reductase Inhibitors And Reduced Prostate Cancer Risk
16 Apr 2008
Federal Authorities Seize More Than 100,000 Dollars Of Unapproved Drugs Marketed As "Natural Read more…
Men’s Health News
Plans are in the pipeline to raise awareness of health issues which affect men in particular.
The Federal Health Minister Nicola Roxon says the government has set in motion plans for the development of Australia’s first health policy for men based on a draft document developed in 1996.
The Health Read more…
Men’s Health News
Low levels of vitamin D appear to be associated with higher risk of myocardial infarction (heart attack) in men, according to a report in the June 9 issue of Archives of Internal Medicine.
Studies have shown that the rates of cardiovascular disease-related deaths are increased at higher latitudes and during the winter months Read more…
Men’s Health News
Normal developmental changes during the teenage years leave young adult men at higher risk of heart disease than their female counterparts, researchers report in Circulation: Journal of the American Heart Association.
"Women’s protective advantage against heart disease starts young," said Antoinette Moran, M.D., lead author of the study and professor and Read more…
UroToday.com - Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy, external beam radiotherapy and interstitial permanent brachytherapy and radical prostatectomy. Treatment decisions should particularly consider the specific risk and toxicity profile of a treatment method.
There is a lack of prospective studies focusing on the Read more…
UroToday.com - A group from the UK led by Bridget Candy report a meta-analysis in the BJU International on phosphodiesterase type 5 inhibitors (PDE5i) for the treatment of erectile dysfunction (ED) secondary to treatments for prostate cancer (CaP).
Only randomized controlled trials were included and outcomes using validated scales such as the IIEF and SEP, successful sexual intercourse, time to effect, treatment satisfaction and health-related Read more…
Despite the fact that it has long been a major concern for men, an evidence-based definition for premature ejaculation has not existed until now. In October 2007, the International Society for Sexual Medicine (ISSM) gathered the world’s leading sexual health experts to develop an evidence-based definition of premature ejaculation. Experts will present the Read more…